Please assess the completion status of the following clinical trial:

Trial Title: Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Greater than or equal to 18 years old~* Able to consent~* Has cutaneous abscess less than or equal to 2 centimeters requiring incision and drainage in the Emergency Department~Exclusion Criteria:~* Less than 18 years old~* Unable to consent~* Pregnant or breastfeeding~* Prisoner or in police custody~* Known sensitivity to vapocoolant or lidocaine~* Cold hypersensitivity~* Chronic steroid use~* Peripheral neuropathy~* Diabetes~* HIV~* Malignancy~* Immunosuppressive state~* Sickle cell disease~* Sarcoidosis~* Abscess greater than 2 centimeters in any dimension~* Abscess requiring procedural sedation and analgesia for incision and drainage, or further intervention outside the Emergency Department~* Abscess located on the hands, feet, face, or perineal areas~* Pilonidal cyst~* hidradenitis suppurativa~* Not a good candidate per attending physician

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): Lidocaine injection will be used for anesthesia prior to incision and drainage. 2% Lidocaine with epinephrine will be injected into the abscess site. Amount injected will be per physician discretion.
- Vapocoolant (Type: ACTIVE_COMPARATOR): Vapocoolant spray will be used for anesthesia prior to incision and drainage. The spray will be administered to the abscess site for a duration of 2 seconds, from a distance of 12 cm.

Based on this trial design, predict the completion outcome and termination type (if applicable).